Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.66%)
As of: Sep 9, 2026 · 3:59 PM EDT

Viatris (VTRS) Free Cash Flow (2019 - 2026)

Viatris (VTRS) posted Free Cash Flow of $329.0 million for Q2 2026, down 5.57% on a QoQ basis from $348.4 million in Q1 2026, and up 97.24% year-over-year from $166.8 million in Q2 2025.

Analysis

Viatris (VTRS) Free Cash Flow (2019 - 2026) Analysis & Trends

Viatris has reported Free Cash Flow for 8 years, with the latest figure at $329.0 million in Q2 2026.

  • On a quarterly basis, Free Cash Flow rose 97.24% year-over-year to $329.0 million in Q2 2026; TTM through Jun 2026 was $2.0 billion, a 11.61% increase from a year earlier, with the FY2025 full-year figure at $1.9 billion, down 2.01% from the prior year.
  • Free Cash Flow was $329.0 million for Q2 2026 at Viatris, down from $348.4 million in the prior quarter.
  • The five-year high for Free Cash Flow was $1.1 billion in Q1 2022, with the low at $35.3 million in Q4 2022.
  • Average Free Cash Flow over 5 years is $539.3 million, with a median of $528.8 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Free Cash Flow plunged 89.16% in 2022, then soared 1041.64% in 2023.
  • Over 5 years, Free Cash Flow stood at $35.3 million in 2022, then jumped by 1041.64% to $403.0 million in 2023, then declined by 15.06% to $342.3 million in 2024, then surged by 80.92% to $619.3 million in 2025, then sank by 46.88% to $329.0 million in 2026.
  • The last three Free Cash Flow figures came in at $329.0 million (Q2 2026), $348.4 million (Q1 2026), and $619.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 307.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 329.00 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 26.40 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -51.94 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 593.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 8.08 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 53.62 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 42.73 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 329.00 Mn
Mar 31, 2026 348.40 Mn
Dec 31, 2025 619.30 Mn
Sep 30, 2025 658.10 Mn
Jun 30, 2025 166.80 Mn
Mar 31, 2025 492.90 Mn
Dec 31, 2024 342.30 Mn
Sep 30, 2024 749.50 Mn
Jun 30, 2024 320.30 Mn
Mar 31, 2024 564.80 Mn
Dec 31, 2023 403.00 Mn
Sep 30, 2023 739.30 Mn
Jun 30, 2023 457.30 Mn
Mar 31, 2023 923.40 Mn
Dec 31, 2022 35.30 Mn
Sep 30, 2022 765.10 Mn
Jun 30, 2022 718.60 Mn
Mar 31, 2022 1.07 Bn
Dec 31, 2021 325.70 Mn
Sep 30, 2021 964.60 Mn